Trials / Completed
CompletedNCT03819647
Evaluation of the Efficacy of Stiripentol (Diacomit) as Monotherapy for the Treatment of Primary Hyperoxaluria
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Biocodex · Industry
- Sex
- All
- Age
- 6 Months
- Healthy volunteers
- Not accepted
Summary
Evaluation of the efficacy of stiripentol (Diacomit) as monotherapy for the treatment of primary hyperoxaluria. Pilot clinical study, open, prospective and multicenter.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | stiripentol (Diacomit) | Administration of stiripentol per os |
Timeline
- Start date
- 2019-05-21
- Primary completion
- 2020-12-18
- Completion
- 2021-03-08
- First posted
- 2019-01-28
- Last updated
- 2021-03-26
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03819647. Inclusion in this directory is not an endorsement.